Exposure of Sensitive Information to an Unauthorized Actor in DEXMA DEXGate
Priority LOW 31CWE-200Published · Updated
Key facts
- Attack vector
- Network
- Privileges required
- None
- User interaction
- None
- Attack complexity
- Low
- Impact type
- Information disclosure
- Confidentiality · integrity · availability
- Low · None · None
- Fix status
- No fix listed
Attack profile from CVSS 3.1 · CNA. Fix status from CNA. Impact type from CWE-200.
Summary
The affected product is vulnerable to an exposure of sensitive information to an unauthorized actor vulnerability, which may allow an attacker to create malicious requests for obtaining the information of the version about the web server used.
Why it matters now
Exploitation None reported CISA SSVC · not in CISA KEV
EPSS 0.00483 41st percentileScored 2026-11-07
Fix No fix listed No fixed version in the sources yet
SSVC decision points
CISA ADP · SSVC 2.0.3
- Exploitation
- None
- Automatable
- Yes
- Technical impact
- Partial
The decision (Track, Attend, Act) also depends on your mission and well-being impact; see CISA's SSVC guide.
Affected products
Remediation
No fixed version listed by the sources yet.
Timeline
- 2026-10-02 Threatist record created from CVE-2023-42666
- 2026-10-03 Alias added: GHSA-7m88-f659-f4w6
References
More DEXMA Dexgate vulnerabilities
- TI-2023-21711 Improper Authentication in DEXMA DEXGate CVSS 3.1HIGH 8.8
- TI-2023-22602 Cross-Site Request Forgery in DEXMA DEXGate CVSS 3.1HIGH 8.8
- TI-2023-21710 Cleartext Transmission of Sensitive Information in DEXMA DEXGate CVSS 3.1MEDIUM 6.5
- TI-2023-21030 Cross-site Scripting in DEXMA DEXGate CVSS 3.1MEDIUM 6.1
Sources
- CVE-2023-42666 · CVE Program
- CVE-2023-42666 · NVD
- FIRST EPSS
- GHSA-7m88-f659-f4w6 · GitHub Advisory Database · CC BY 4.0
This product uses the NVD API but is not endorsed or certified by the NVD. Sources and licences